Paxlovid reduces risk of Long COVID
Nov 7, 2022
Today, VA released a study showing the medication Paxlovid can reduce the risk of symptoms of ‘Long COVID,’ which affects millions of people in the U.S. and around the world. In the interest of public health, the study, ‘Nirmatrelvir and the risk of post-acute sequelae of COVID-19,’ was released before peer-review on the pre-print server medRxiv.
Read more from the VA: Read More
